Development and characterization of a nano-scale contrast agent.
about
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery.A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer TherapyUltrasound imaging beyond the vasculature with new generation contrast agentsUltrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenograftsPreparation and characterization of a novel silicon-modified nanobubbleUltrasound contrast-enhanced imaging and in vitro antitumor effect of paclitaxel-poly(lactic-co-glycolic acid)-monomethoxypoly (ethylene glycol) nanocapsules with ultrasound-targeted microbubble destruction.India ink incorporated multifunctional phase-transition nanodroplets for photoacoustic/ultrasound dual-modality imaging and photoacoustic effect based tumor therapyPreparation of nanobubbles carrying androgen receptor siRNA and their inhibitory effects on androgen-independent prostate cancer when combined with ultrasonic irradiation.Microbubbles in ultrasound-triggered drug and gene deliveryNanobubbles for enhanced ultrasound imaging of tumors.Estimating the shell parameters of SonoVue microbubbles using light scattering.Design of vitamin E d-α-Tocopheryl Polyethylene Glycol 1000 Succinate-Emulsified Poly (D,L-Lactide-co-Glycolide) Nanoparticles: Influence of Duration of Ultrasonication Energy.Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.Synthesis and evaluation of perfluorooctylbromide nanoparticles modified with a folate receptor for targeting ovarian cancer: in vitro and in vivo experiments.The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor ImagingSize effect of Au/PAMAM contrast agent on CT imaging of reticuloendothelial system and tumor tissue.Polymeric microbubbles for ultrasonic molecular imaging and targeted therapeutics.Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery.Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization.Materials Chemistry of Nanoultrasonic Biomedicine.Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors.Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.Laccase-mediated formation of mesoporous silica nanoparticle based redox stimuli-responsive hybrid nanogels as a multifunctional nanotheranostic agent.The in vitro study of Her-2 targeted gold nanoshell liquid fluorocarbon poly lactic-co-glycolic acid ultrasound microcapsule for ultrasound imaging and breast tumor photothermal therapy.Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model.Micro/Nanoparticle-Augmented Sonodynamic Therapy (SDT): Breaking the Depth Shallow of Photoactivation.The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destructionOrganic-Inorganic Hybrid Hollow Mesoporous Organosilica Nanoparticles for Efficient Ultrasound-Based Imaging and Controlled Drug Release
P2860
Q26781564-607778D0-DDE2-41DA-A450-2F2C3BCF9CCCQ27300884-00A18004-A76A-4284-93CA-481E8822E2E6Q27691825-1C2D5A08-0642-4E1E-BD0A-FF039FCB3003Q28487464-76EED5B0-D6E3-4B3A-A287-B7D00BDAFA17Q30354191-72FC51B7-B8B2-440D-8AE9-9A2D722995B1Q30417170-A452B4B4-DA81-4728-AE48-D50DE88FDED2Q30432452-1E2EC3BA-97F5-474C-9EE3-72064213A3C1Q30438691-2CF9524B-4302-42F0-9F0F-28FC0B25111BQ30438994-24C5E93A-D723-4A84-99C7-EDF9D6A570B1Q30469828-545CF615-B1AB-48A7-8FF7-37E1E8ABD6ECQ30478404-01069547-0C76-4F62-B901-13CF66F0A48FQ34012664-F51DADBF-7C88-4876-9B74-F7FC33E208E9Q34094167-2F1B9FD5-994A-4420-9429-ED71559AEA3DQ35756395-9FE4E977-6B1B-4538-9DCF-B3443AD410C9Q36022403-AAC3949D-A26C-4AC7-AC2F-218A9EC0EFD3Q37284538-3CC5EFC3-CECE-428E-8AAF-AD0AC316A7F5Q37818649-570BD707-EF67-453F-8848-E266D1B18302Q38217698-211846E9-AFA3-4D45-B872-D12C1D1E6FFDQ38827418-152534AC-D451-4D3D-B458-30139948D20AQ39043064-F92CAA33-14FF-4E29-A45C-2CC59DF93499Q39136986-548A7577-5560-42B6-AC90-64E9EBFCEF33Q45877188-6CBC174E-E9A9-412D-8C65-FEC414E1332FQ48054189-2770A8D4-CB96-4EBD-ADA3-363F4DB08F41Q48610763-DFEF1F70-DD5A-43FD-A263-5100C42012C8Q49589433-F2F1C6CD-57A2-4697-98EC-FB4CA6D5C30AQ50788001-9A12D02A-F236-463F-B3DD-7A435B0A88EDQ58698613-76DDB76B-051B-4785-9D5A-DC63F2B8E0B0Q59059654-49430E22-E209-4027-AB33-86976FE05DF0
P2860
Development and characterization of a nano-scale contrast agent.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Development and characterization of a nano-scale contrast agent.
@ast
Development and characterization of a nano-scale contrast agent.
@en
type
label
Development and characterization of a nano-scale contrast agent.
@ast
Development and characterization of a nano-scale contrast agent.
@en
prefLabel
Development and characterization of a nano-scale contrast agent.
@ast
Development and characterization of a nano-scale contrast agent.
@en
P1433
P1476
Development and characterization of a nano-scale contrast agent.
@en
P2093
Brian E Oeffinger
Margaret A Wheatley
P304
P356
10.1016/J.ULTRAS.2003.11.011
P577
2004-04-01T00:00:00Z